(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
Live Chart Being Loaded With Signals
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands...
Stats | |
---|---|
Šios dienos apimtis | 133.28M |
Vidutinė apimtis | 5.07M |
Rinkos kapitalizacija | 4.49M |
EPS | $0 ( 2024-05-09 ) |
Kita pelno data | ( $-0.150 ) 2024-05-28 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0300 |
ATR14 | $0.00100 (0.84%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-09 | Freiman Paul E. | Buy | 858 | Restricted Stock Units |
2023-06-09 | Garlikov Julie | Buy | 858 | Restricted Stock Units |
2023-06-09 | Zheng Yenyou | Buy | 858 | Restricted Stock Units |
2023-06-09 | Zheng Yongxiang | Buy | 858 | Restricted Stock Units |
2023-06-09 | Sit Swan | Buy | 858 | Restricted Stock Units |
INSIDER POWER |
---|
-62.74 |
Last 96 transactions |
Buy: 2 335 940 | Sell: 2 184 002 |
Tūris Koreliacija
NovaBay Pharmaceuticals Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
NovaBay Pharmaceuticals Koreliacija - Valiuta/Žaliavos
NovaBay Pharmaceuticals Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $14.73M |
Bruto pelnas: | $7.90M (53.61 %) |
EPS: | $-2.29 |
FY | 2023 |
Pajamos: | $14.73M |
Bruto pelnas: | $7.90M (53.61 %) |
EPS: | $-2.29 |
FY | 2022 |
Pajamos: | $14.40M |
Bruto pelnas: | $7.78M (54.02 %) |
EPS: | $-10.10 |
FY | 2021 |
Pajamos: | $8.42M |
Bruto pelnas: | $5.65M (67.03 %) |
EPS: | $-9.42 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.